ProxsysRx
Birmingham, US · Delaware corporation · 1 known investors
ProxsysRx builds and operates on-site outpatient retail pharmacies for hospital systems and manages 340B drug pricing programs, PBM alignment, readmission reduction, and patient financial assistance. It serves hospitals and health systems, providing pharmacy operations, analytics, and compliance reporting at no direct cost to the hospital.
Founders & leadership
GB
George B SalemNamed on SEC filing
GR
Gene Ruffner PageNamed on SEC filing
TN
Thomas NelsonNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.6M disclosed across 1 round · 2020
▶$14.6MraisedNov 2020 · 6 investors · Other Health CareRule 506(b)
▶$14.6MraisedNov 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- George B SalemExecutive Officer, Director
- Gene Ruffner PageDirector
- Thomas NelsonExecutive Officer
- Offering amount
- $14.6M
- Amount sold
- $14.6M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapVytlOne215 shared keywordsVytlOne is an independent provider of integrated pharmacy solutions, combining pharmacy benefit management (PBM) and pharmacy services for hospitals, health systems, health centers, and employers. It offers custom pharmacy benefit plans and an AI platform (VytlAIQ) for 340B and specialty pharmacy operations.
Aha120 shared keywordsContent references the American Hospital Association's national advisory work on cybersecurity and risk for the U.S. healthcare field, including analysis of cyberattacks targeting hospitals and health systems.
Companies competing with ProxsysRx for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ProxsysRx do?
- ProxsysRx builds and operates on-site outpatient retail pharmacies for hospital systems and manages 340B drug pricing programs, PBM alignment, readmission reduction, and patient financial assistance. It serves hospitals and health systems, providing pharmacy operations, analytics, and compliance reporting at no direct cost to the hospital.
- Who are ProxsysRx's investors?
- ProxsysRx's investors include Fulcrum Equity Partners.
- How much funding has ProxsysRx raised?
- ProxsysRx has disclosed $14.6M raised across 1 round.
- Where is ProxsysRx headquartered?
- ProxsysRx is headquartered in Birmingham, US.